Ibuprofen Decoy
Pain-reliever ibuprofen makes enzyme oxidize styrene with hydrogen peroxide
enzymes can be efficient biocatalysts for organic synthesis, but often only work on a small range of specific substrates. Yoshihito Watanabe and colleagues at Nagoya University and RIKEN (Japan) have tricked enzymes into catalyzing reactions between molecules of choice, they report in Chemistry—An Asian Journal. By using organic acids, including the pain reliever ibuprofen, they mimicked the natural substrate.
The researchers used one member of the family of so-called cytochrome P450 enzymes, which owe their catalytic activity to the same heme group that binds oxygen in hemoglobin in the blood. They were able to expand its substrate scope by using organic acids to simulate substrate binding. The carboxylic acid group activates the H2O2 oxidant, which finally results in oxidation of the heme iron atom and generation of the active species.
This "decoy" approach allows epoxidation of styrene, which cannot normally be achieved with P450 enzymes. When an asymmetric decoy is used, such as the common pain reliever ibuprofen, the epoxidation proceeds stereoselectively: Only the desired molecule is produced, but not its mirror image, which can make the difference between a drug and a poison.
Further optimization of the system both in terms of decoy molecule and P450 mutant should yield higher catalytic activity and better stereoselectivity. This method should prove valuable in expanding the use of enzymes in organic synthesis.
Original publication
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

A taste for plastic - Discovered for the first time: New deep-sea enzyme breaks down PET plastic

A 'bio-refinery': using the chemistry of willow trees to treat municipal wastewater - Millions of litres of primary municipal wastewater can be treated sustainably using fast-growing willow trees while also producing renewable bioenergy and ‘green’ chemicals
Successful restart at Köttermann

Only alcohol -- not caffeine, diet or lack of sleep -- might trigger heart rhythm condition - Lifestyle factors may play role in managing the malady, latest study shows

How a SARS-CoV-2 infection can become severe COVID-19 - Severity is linked to disruption of the endothelial barrier and can be measured by looking at inflammatory and endothelial plasma proteins

Proteins roll the dice to determine bee sex - “We have been able to solve a genetic mystery that has existed for more than 100 years"
